Dealing with anxiety is challenging. Whether it’s induced by stress, work, hormonal imbalance, or other reasons, anxiety can ...

Cardiff Oncology's phase 2 trial of onvansertib in mCRC shows promising results, with improved response rates and potential ...

The Haryana government has notified 16 essential services under the Right to Service Act, aimed at enhancing the efficiency of Metropolitan Development Authorities in Gurugram and Faridabad, including ...

MG’s next electric car for Australia has been approved for sale, with three battery sizes – and a different name to what’s ...

It was a busy week in the biotech sector with lots of data readouts. This apart, the key regulatory updates and pipeline news ...

Cardiff Oncology's promising Phase 2 trial data for Onvansertib in colorectal cancer may lead to accelerated FDA approval, ...

Cardiff Oncology’s investigational PLK1 inhibitor paired with standard-of-care treatment showed a 64% overall response rate ...

Social media warnings, food insecurity, unsafe hospitals, "forever chemicals," underinsured put off care, AI, vaccines, and ...

Palazestrant, in combination with ribociclib, demonstrated promising clinical activity, a safety profile consistent with ribociclib and endocrine ...

Initial results from randomized Phase 2 CRDF-004 trial evaluating onvansertib + standard of care in RAS-mut mCRC demonstrated ...